Patent · US Active

Materials and methods for assessing progression of prostate cancer

US9994912B2 · kind B2 · utility

0Cited by
11References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2015
Grant dateJun 12, 2018
Priority date
Expiry dateJul 20, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods of distinguishing and identifying a patient with aggressive/indolent, prostatic adenocarcinoma comprising contacting a sample from the patient with a set of detectably labeled probes under hybridization conditions and determining the presence of chromosomal abnormalities in the sample; sets of probes for use in such methods; and kits comprising a set of probes and instructions for distinguishing or identifying a patient as having aggressive/indolent, prostatic adenocarcinoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.